Delivery Order SPE2DB24D2106-SPE2DB24FAUSC
Award Date
8/15/24
Potential Completion Date
8/16/24
Potential Value
$9.4K
Federal Agency
Defense Logistics Agency
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $2,589.87 contract is for the delivery of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, with a completion date of May 19, 2025. DMS Pharmaceutical Group Inc. holds a significant $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue delivery orders for a...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of Typhim VI 25 mcg/0.5 mL vial, 10 mL, a vaccine product, with a ceiling value of $1,040.42 and a completion date of September 23, 2024. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract is for the delivery of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a specialized pharmaceutical product, with a ceiling value of $3,015.30 and a period of performance ending on February 18, 2025. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $20,658.62 contract is for the delivery of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a pharmaceutical product, with a period of performance through December 19, 2024. DMS Pharmaceutical Group Inc. holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $2,589.87, is for the supply of 10 mL vials of the TYPHIM VI 25 MCG/0.5 ML vaccine. The contract has a firm fixed price and an ultimate completion date of April 24, 2025. DMS Pharmaceutical Group Inc. has a larger Indefinite Delivery Contract (IDC) with the DLA under the...
This firm fixed-price delivery order was awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,040.42 contract is for the supply of 4565900982 - TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, with a period of performance through September 23, 2024. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDC) with the DLA under the SPE2DB...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, valued at $2,781.69, is for the delivery of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a pharmaceutical product. The contract is a firm fixed-price delivery order, with an ultimate completion date of April 17, 2025. DMS Pharmaceutical Group Inc. has a larger indefinite delivery contract (IDC) with the DLA under the...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $8,761.60 contract is for the supply of Typhim VI 25 mcg/0.5 mL vaccine vials, with a performance period through January 13, 2022. The award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,482.00, is for the delivery of Typhoid VI Polysaccharide vaccines. The contract has an ultimate completion date of May 12, 2025. DMS Pharmaceutical Group Inc. has a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $4,636.15 contract is for the delivery of Typhoid VI Polysaccharide, a medical product, with a performance period through May 2025. DMS Pharmaceutical Group holds a significant $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue delivery orders...